Sugi Predict

Sugi Predict / Compounds / SCHEMBL1070461

SCHEMBL1070461

SCHEMBL1070461

COC(=O)c1cc(Br)c(C)c(Br)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 4/20 0.54
▸ CA2 P00918 4/20 0.54
▸ CA12 O43570 3/20 0.54
▸ CA7 P43166 3/20 0.54
▸ CA9 Q16790 3/20 0.54
▸ CA14 Q9ULX7 3/20 0.54
▸ KDM4E B2RXH2 5/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ XDH P47989 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ GFER P55789 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52
▸ FUT7 Q11130 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ NOTUM Q6P988 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19357846 0.90 CA12 (0.48) CA1CA2CA12CA7CA9
SCHEMBL29710347 0.90 CA12 (0.48) CA1CA2CA12CA7CA9
SCHEMBL30003562 0.88 CA12 (0.47) CA1CA2CA12CA7CA9
SCHEMBL27091761 0.88 CA12 (0.47) CA1CA2CA12CA7CA9
SCHEMBL18585192 0.87 KDM4E (0.50) CA1CA2CA12CA7CA9
SCHEMBL16069743 0.87 CNR2 (0.53) CA1CA2CA12CA7CA9
SCHEMBL29528983 0.87 CA12 (0.46) CA1CA2CA12CA7CA9
SCHEMBL22400330 0.87 CA12 (0.46) CA1CA2CA12CA7CA9
SCHEMBL22400356 0.87 HDAC1 (0.50) CA1CA2CA12CA7CA9
SCHEMBL30390110 0.87 HDAC1 (0.50) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6306203-B1 FOR USE IN INK JET PRINTING, INCLUDING PIEZOELECTRIC INK JET PRINTING AND ACOUSTIC INK JET PRINTING XEROX CORPORATION 2001-10-23 — — US claimed
US-20240324442-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-09-26 — — US disclosed
CN-118652279-A Organic electroluminescent material and device 环球展览公司 2024-09-17 — — CN disclosed
US-20240295548-A1 PHOTOAFFINITY PROBES PROMEGA CORPORATION 2024-09-05 — — US disclosed
CN-118406213-A Polymer self-assembled interface material, preparation method and application thereof, and preparation method of laminated solar cell 宣城先进光伏技术有限公司 2024-07-30 — — CN disclosed
CN-117658899-A Porphyrin polymer film with bipyridine as bridging group, and preparation method and application thereof 广东第二师范学院 2024-03-08 — — CN disclosed
US-11913944-B2 Photoaffinity probes PROMEGA CORPORATION (US) 2024-02-27 — — US disclosed
US-11913944-B2 Photoaffinity probes PROMEGA CORPORATION (US) 2024-02-27 — — US disclosed
US-11913944-B2 Photoaffinity probes PROMEGA CORPORATION (US) 2024-02-27 — — US disclosed
EP-3941195-A1 PHOTOAFFINITY PROBES PROMEGA CORPORATION (US) 2022-01-26 — — EP disclosed
WO-2003064376-A1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2003-08-07 — — WO disclosed
US-20030092712-A1 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents MERCK SHARP & DOHME CORP. 2003-05-15 — — US disclosed
WO-2002058695-A1 (HALO-BENZO CARBONYL)HETEROCYCLO FUSED PHENYL P38 KINASE INHIBITING AGENTS MERCK & CO., INC. (US) 2002-08-01 — — WO disclosed
US-6320051-B1 AMINO(NH) OR OXYGEN(O) SUBSTITUTED, ENZYME INHIBITORS OF STAPHLOCCOCUS AUREUS METHIONYL T-RNA SYNTHETASE (MRS); ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM PLC (GB) 2001-11-20 — — US disclosed
US-6306203-B1 FOR USE IN INK JET PRINTING, INCLUDING PIEZOELECTRIC INK JET PRINTING AND ACOUSTIC INK JET PRINTING XEROX CORPORATION 2001-10-23 — — US disclosed
EP-1084110-A1 QUINOLONES USED AS MRS INHIBITORS AND BACTERICIDES SMITHKLINE BEECHAM PLC (GB) 2001-03-21 — — EP disclosed
EP-0733033-B1 PHARMACEUTICALLY ACTIVE SUBSTITUTED AROMATIC COMPOUNDS ZENECA LTD (GB) 1999-12-22 — — EP disclosed
WO-1999055677-A1 QUINOLONES USED AS MRS INHIBITORS AND BACTERICIDES SMITHKLINE BEECHAM PLC (GB) 1999-11-04 — — WO disclosed
US-5811459-A PAIN RELIEVERS ZENECA LIMITED (GB) 1998-09-22 — — US disclosed
US-4218567-A Process for aromatic ethers HOFFMANN-LA ROCHE INC. (US) 1980-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240324442-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES KCNH2, KCNH3, KCNB2 CA1 834/4885CA2 2215/4885CA12 2000/4885
US-20030092712-A1 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents MAPK1, MAPK7, MAPKAPK2 CA1 2762/4885CA2 1179/4885CA12 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.